OGN Stock Recent News

Organon's (OGN) first-quarter results are likely to reflect growth in its biosimilars and established brand franchises with lighter fertility product sales amid foreign exchange headwinds.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Organon (OGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.

Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Organon (OGN) reachead $18.71 at the closing of the latest trading day, reflecting a +1.03% change compared to its last close.

In the closing of the recent trading day, Organon (OGN) stood at $18, denoting a +1.01% change from the preceding trading day.

In the latest trading session, Organon (OGN) closed at $17.71, marking a +1.49% move from the previous day.

In the most recent trading session, Organon (OGN) closed at $18.16, indicating a +1.68% shift from the previous trading day.

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024.

Now may be an ideal time to buy these lower-risk, high-income stocks especially as markets start to digest hot inflationary data.

Now looks like a good time to buy these highly ranked stocks with earnings estimate revisions likely to keep ticking up after their favorable Q4 results which makes their high dividend yields and low beta ratios more attractive.